PSYCHOMOTILITY AND PARKINSONISM IN TREATMENT WITH NEUROLEPTIC DRUGS

[1] BING R, 1947, LEHRBUCH NERVENKRANK, P136

[2] DELAY J, 1956, J Clin Exp Psychopathol, V17, P19

[3] Freyhan FA, 1957, ENCEPHALE, V45, P913

[4] FREYHAN FA, 1955, PSHUASKFL, P71

[5] Haase HJ, 1955, NERVENARZT, V26, P507

[6] NEUROTOXIC REACTIONS RESULTING FROM CHLORPROMAZINE ADMINISTRATION [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1956, 161 (03): : 214 - 218

[7] HESS WR, 1954, MONOGRAPHS BIOL MED, V3

[8] KRETSCHMER E, 1952, TXB MED PSYCHOL

[9] LAZARTE JA, 1955, P STAFF M MAYO CLIN, V30, P358

[10] Lehmann HE, 1954, NERVENARZT, V25, P322

[1] BING R, 1947, LEHRBUCH NERVENKRANK, P136

[2] DELAY J, 1956, J Clin Exp Psychopathol, V17, P19

[3] Freyhan FA, 1957, ENCEPHALE, V45, P913

[4] FREYHAN FA, 1955, PSHUASKFL, P71

[5] Haase HJ, 1955, NERVENARZT, V26, P507

[6] NEUROTOXIC REACTIONS RESULTING FROM CHLORPROMAZINE ADMINISTRATION [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1956, 161 (03): : 214 - 218

[7] HESS WR, 1954, MONOGRAPHS BIOL MED, V3

[8] KRETSCHMER E, 1952, TXB MED PSYCHOL

[9] LAZARTE JA, 1955, P STAFF M MAYO CLIN, V30, P358

[10] Lehmann HE, 1954, NERVENARZT, V25, P322